-
BTIG Reiterates Buy Rating on Embecta (EMBC)
-
Embecta (EMBC) October 17.5 calls active
-
Embecta (EMBC) PT Raised to $14 at Mizuho
-
Embecta Corp. (EMBC) Tops Q3 EPS by 35c, Beats on Revenue; Offers FY25 Guidance
-
Embecta (EMBC) PT Lowered to $18 at BofA Securities
-
Embecta Corp. (EMBC) Tops Q2 EPS by 17c ; Offers Guidance
-
Mizuho Starts Embecta (EMBC) at Neutral
-
BTIG Upgrades Embecta (EMBC) to Buy
-
Embecta (EMBC) Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

